Fullerene Derivative
FMLP + FD*
poly-L-lysine + FD*
Ethanolamine
no Inh
no Inh
Niacin
86.6 (±16.6)
¥¥¥
no Inh
Tetrainositol
54.8 (±19.3)
¥
no Inh
TGA
83.7 (±19.0)
¥¥
no Inh
* FD Treatment at 10 µg/mL.
¥¥¥
p
value < 0.01 /
¥¥
p
value < 0.02 /
¥
p
value < 0.05
no Inh = no significant inhibition observed
Table 5:
Mean % inhibition of IL-13 (±SD) in FD treated and untreated PBB.
